The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese Society of Chemotherapy

Journal of Infection and Chemotherapy

Volumn 17, Issue 1, 2011, Pages 126-138

  Ishikawa, Kiyohito ^a,g   Matsumoto, Tetsuro ^a,w   Yasuda, Mitsuru ^a,j   Uehara, Shinya ^a   Muratani, Tetsuro ^a   Yagisawa, Morimasa ^a   Sato, Junko ^a   Niki, Yoshihito ^a   Totsuka, Kyoichi ^a   Sunakawa, Keisuke ^a   Hanaki, Hideaki ^b   Hattori, Rikizo ^a   Terada, Michinori ^a   Kozuki, Tsuneo ^a   Maruo, Akinori ^a   Morita, Kohei ^a   Ogasawara, Kazuhiko ^a   Takahashi, Yoshisaburo ^a   Matsuda, Kenji ^a   Hirose, Takaoki ^c   Miyao, Noriomi ^d   Hayashi, Tasuku ^d   Takeyama, Koh ^e   Kiyota, Hiroshi ^f   Tomita, Masayuki ^f   Yusu, Hisashi ^f   Koide, Haruhisa ^f   Kimura, Shoji ^f   Yanaoka, Masanori ^h   Sato, Hajime ^h   Ito, Toru ⁱ   Deguchi, Takashi ^j   Fujimoto, Yoshinori ^k   Komeda, Hisao ^k   Asano, Yuko ^k   Takahashi, Yoshito ^l   Ishihara, Satoshi ^m   Arakawa, Soichi ⁿ   Nakano, Yuzo ⁿ   Tanaka, Kazushi ⁿ   Fujisawa, Masato ⁿ   Matsui, Takashi ^o   Fujii, Akira ^p   Yamamoto, Shingo ^q   Nojima, Michio ^q   Higuchi, Yoshihide ^q   Ueda, Yasuo ^q   Kanamaru, Sojun ^r   Monden, Koichi ^s   Tsushima, Tomoyasu ^t   Seno, Yuko ^t   Tsugawa, Masaya ^u   Takenaka, Tadasu ^v   Hamasuna, Ryoichi ^w   Fujimoto, Naohiro ^w   Sho, Takehiko ^w   Takahashi, Koichi ^x   Inatomi, Hisato ^y   Takahashi, Naoya ^z   Ikei, Yoshihiko ^z   Hayami, Hiroshi ^aa   Yamane, Takashi ^aa   Nakagawa, Masayuki ^aa   Kariya, Satoru ^ab   Arima, Takashi ^ac   more..

^a Japanese Society of Chemotherapy   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c Hokkaido Social Insurance Hospital   (Japan)

^d Muroran City General Hospital   (Japan)

^e National Hospital Organization Hakodate Hospital   (Japan)

^f JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g FUJITA HEALTH UNIVERSITY   (Japan)

^h SHIZUOKA RED CROSS HOSPITAL   (Japan)

ⁱ Nagoya Ekisaikai Hospital   (Japan)

^j GIFU UNIVERSITY HOSPITAL   (Japan)

^k OGAKI MUNICIPAL HOSPITAL   (Japan)

^l GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^m Kizawa Memorial Hospital   (Japan)

ⁿ KOBE UNIVERSITY HOSPITAL   (Japan)

^o Red Cross Kobe Hospital   (Japan)

^p Nippon Steel Hirohata Hospital   (Japan)

^q HYOGO COLLEGE OF MEDICINE   (Japan)

^r NISHI KOBE MEDICAL CENTER   (Japan)

^s Araki Urological Clinic   (Japan)

^t NATIONAL HOSPITAL ORGANIZATION   (Japan)

^u Okayama Citizens Hospital   (Japan)

^v Japanese Red Cross Okayama Hospital   (Japan)

^w UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^x Fukuoka Shin Mizumaki Hospital   (Japan)

^y Munakata Suikoukai General Hospital   (Japan)

^z Ikei Hospital   (Japan)

^aa KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^ab NATIONAL HOSPITAL ORGANIZATION KAGOSHIMA MEDICAL CENTER   (Japan)

^ac Tarumizu Chuo Hospital   (Japan)

more..

Author keywords

Drug susceptibility; Surveillance; Urinary tract infection

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; BIAPENEM; CARBAPENEM DERIVATIVE; CEFACLOR; CEFAZOLIN; CEFCAPENE; CEFDITOREN; CEFEPIME; CEFMETAZOLE; CEFOTIAM; CEFPIROME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; DORIPENEM; EXTENDED SPECTRUM BETA LACTAMASE; FLOMOXEF; IMIPENEM; LINEZOLID; MEROPENEM; PANIPENEM; PENICILLIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNINDEXED DRUG; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CROSS RESISTANCE; DISEASE SURVEILLANCE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SERRATIA MARCESCENS; URINARY TRACT INFECTION;

EID: 79951551846     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-010-0174-1     Document Type: Article

References (42)

1. CW Burt SM Schappert 2004 Ambulatory care visits to physician offices, hospital outpatients departments, and emergency departments: United States Vital Health Stat 13 1 70
2. KG Naber B Bergman MC Bishop, et al. 2001 Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). EAU guidelines for the management of urinary and male genital tract infection Eur Urol 40 576 588 1:STN:280:DC%2BD38%2Fkt1eksA%3D%3D 10.1159/000049840 11752870 (Pubitemid 34289761)
3. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 16th informational supplement M100-S16 and M45-P. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 7th edn. Document M7-A7. Wayne, PA: Clinical and Laboratory Standards Institute; 2006.
4. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 18th informational supplement M100-S18. Document M7-A7. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
5. H Hanaki R Kubo T Nakano M Kurihara K Sunagawa 2004 Characterization of HMRZ-86; a novel chromogenic cephalosporin for the detection of extended-spectrum beta-lactamases J Antimicrob Chemother 53 888 889 1:CAS:528:DC%2BD2cXjs1Wqtr0%3D 10.1093/jac/dkh166 15056644 (Pubitemid 38660301)
6. R Colodner B Rezik V Gal H Yamazaki H Hanaki R Kubo 2006 Evaluation of a novel kit for the rapid detection of extended-spectrum beta-lactamase Eur J Clin Microb Infect Dis 25 49 51 1:CAS:528:DC%2BD28XhtVaisrk%3D 10.1007/s10096-005- 0074-y (Pubitemid 43207331)
7. HC Neu 1982 Urinary tract infections Am J Med 307 637 642
8. RN Jones 1996 Impact of changing pathogens and antimicrobial susceptibility pattern in the treatment of serious infections in hospitalized patients Am J Med 100 suppl 6A S3 S12 10.1016/S0002-9343(96)00102-7
9. DA Brosnema JR Adams R Pallares RP Wenzel 1993 Secular trends in rates and etiology of nosocomial urinary tract infections at a university hospital J Urol 150 414 416 (Pubitemid 23215882)
10. CF Acar FW Goldstein 1997 Trends in bacterial resistance to fluoroquinolones Clin Infect Dis 24 suppl 1 S67 S73 1:CAS:528: DyaK2sXms1GjsQ%3D%3D 8994781
11. PA Margariti AL Astorri C Mastromarino 1997 Urinary tract infections: risk factors and therapeutic trends Recent Prog Med 88 65 68 1:STN:280:DyaK2s3ltlKrtw%3D%3D (Pubitemid 27207223)
12. K Thomson WE Sanders CC Sanders 1994 United States of America resistance patterns among urinary tract infections pathogens J Antimicrob Chemother 33 suppl A 9 15 1:CAS:528:DyaK2cXltVelt7s%3D 7928840
13. LE Nicolle 2002 Urinary tract infection: traditional pharmacologic therapies Am J Med 113 suppl 1A 35 44 10.1016/S0002-9343(02)01058-6
14. K Gupta TM Hooton CL Wobbe WE Stamm 1999 The prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in young women Int J Antimicrob Agents 11 305 308 1:CAS:528:DyaK1MXjslGitLw%3D 10.1016/S0924-8579(99)00035-7 10394988 (Pubitemid 29231980)
15. DF Sahm C Thornsberry DC Mayfield ME Jones JA Karlowsky 2001 Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000 Antimicrob Agents Chemother 45 1402 1406 1:CAS:528:DC%2BD3MXjtF2hu7g%3D 10.1128/AAC.45.5.1402-1406.2001 11302802 (Pubitemid 32374109)
16. GG Zhanel TL Hisanaga NM Laing MR DeCorby KA Nichol LP Palatnik the NAUTICA Group 2005 Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA) Int J Antimicrob Agents 26 380 388 1:CAS:528:DC%2BD2MXhtFeitbfL 10.1016/j.ijantimicag.2005.08.003 16243229 (Pubitemid 41483468)
17. AG Carrie CJ Metge DM Collins GKM Harding GG Zhanel 2004 Use of administrative healthcare claims to examine the effectiveness of trimethoprim-sulfamethoxazole versus fluoroquinolones in the treatment of community-acquired acute pyelonephritis in women J Antimicrob Chemother 53 512 517 1:CAS:528:DC%2BD2cXhvFSrtr4%3D 10.1093/jac/dkh100 14749344 (Pubitemid 38380252)
18. KM Killgore KL March BJ Gugleilmo 2004 Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection Ann Pharmacother 38 1148 1152 1:CAS:528:DC%2BD2cXlvFemsrk%3D 10.1345/aph.1D622 15150380 (Pubitemid 38802150)
19. K Gupa WE Stamm 2003 Outcomes associated with trimethoprim/ sulphamethoxazole (TMP/SMX) therapy in TMP/SMX resistant community-acquired urinary tract infections Int J Antimicrob Agents 2 65 72
20. R Raz B Chazzan Y Kennes R Colodner E Rottensterich M Dan Israeli Urinary Tract Infection Group, et al. 2002 Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens Clin Infect Dis 34 1165 1169 1:CAS:528:DC%2BD38XjvFGht7g%3D 10.1086/339812 11941541 (Pubitemid 34450662)
21. DA Talan WE Stamm TM Hooton GJ Moran T Burke A Iravani, et al. 2000 Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial JAMA 283 1583 1590 1:CAS:528:DC%2BD3cXisVehsr4%3D 10.1001/jama.283.12.1583 10735395 (Pubitemid 30161514)
22. HY Chenia B Pillay D Pillay 2006 Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens J Antimicrob Chemother 58 1274 1278 1:CAS:528:DC%2BD28Xht1Ogsr7J 10.1093/jac/dkl404 17040923 (Pubitemid 44884152)
23. G Piatti A Mannini M Balistreri AM Schito 2008 Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance J Clin Microbiol 46 480 487 1:CAS:528: DC%2BD1cXis1ehsro%3D 10.1128/JCM.01488-07 18057134 (Pubitemid 351231290)
24. K Uema T Kagawa H Takigawa K Kurokawa 1987 Clinical bacterial investigation in inpatients of department of urology Nishinihon Hinyoukika 49 1089 1098
25. K Ishikawa S Hayakawa S Miyakawa M Kusaka R Shiroki K Hoshinaga 2005 Survey of the susceptibility of urinary isolates to antibacterial agents in 2003 J Infect Chemother 11 44 47 1:CAS:528:DC%2BD2MXhsF2ltLk%3D 10.1007/s10156-004- 0356-9 15729488 (Pubitemid 40379482)
26. K Ishikawa S Miyakawa T Tanaka Y Naide R Shiroki K Hoshinaga 2004 The trend and susceptibility to antibacterial agents of Enterococcus species from urinary tract infections Jpn J Urol 95 25 34 (Pubitemid 38197130)
27. T Matsumoto H Kiyota M Matsukawa M Yasuda S Arakawa K Monden Japanese Society of UTI Cooperative Study Group 2007 Japanese guideline for prevention of perioperative infections in urological field Int J Urol 14 890 909 10.1111/j.1442-2042.2007.01869.x 17880286 (Pubitemid 47432549)
28. H Aeslan OK Azap O Erqonul F Timurkaynak 2005 Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infection in Turkey J Antimicrob Chemother 56 914 918 10.1093/jac/dki344 (Pubitemid 41631917)
29. Ena J, Amador C, Martinez C, Ortiz de la Tabla V. Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli. J Urol 1995;153:117-120.
30. J Ortiz MC Vila G Soriano J Miñana J Gana B Mirelis, et al. 1999 Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients Hepatology 29 1064 1069 1:CAS:528:DyaK1MXisVKgsLw%3D 10.1002/hep.510290406 10094947 (Pubitemid 29168737)
31. A Sotto CM De Boever P Fabbro-Peray A Gouby D Sirot J Jourdan 2001 Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study J Clin Microbiol 39 438 444 1:STN:280:DC%2BD3M3ktlyksg%3D%3D 10.1128/JCM.39.2.438-444.2001 11158087 (Pubitemid 32150799)
32. AS Jellen-Ritter WV Kern 2001 Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with a fluoroquinolone Antimicrob Agents Chemother 45 1467 1472 1:CAS:528:DC%2BD3MXjtF2gsrg%3D 10.1128/AAC.45.5.1467- 1472.2001 11302812 (Pubitemid 32374119)
33. MN Alekshun SB Levy 2007 Molecular mechanisms of antibacterial multidrug resistance Cell 128 1037 1050 1:CAS:528:DC%2BD2sXkslGmsrc%3D 10.1016/j.cell.2007.03.004 17382878 (Pubitemid 46427883)
34. L Martinez-Martinez S Hernandez-Alles S Alberti JM Tomas V Benedi GA Jacoby 1996 In vivo selection of porin-deficient mutations of Klebsiella pneumoniae with increased resistance to cefoxitin and extended-spectrum cephalosporins Antimicrob Agents Chemother 40 342 348 1:CAS:528: DyaK28Xos1WmtQ%3D%3D 8834877 (Pubitemid 26049344)
35. B Pangon C Bizet A Bure F Pichon A Phillipon B Regnier, et al. 1989 In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 β-lactamase J Infect Dis 159 1005 1006 1:CAS:528:DyaL1MXktlKmsr4%3D 2651531 (Pubitemid 19113092)
36. PJ Jenks YM Hu F Danel S Mehtar DM Livermore 1996 Plasmid-mediated production of class I (AmpC) β-lactamase by two Klebsiella pneumoniae isolates from the UK J Antimicrob Chemother 35 235 236 10.1093/jac/35.1.235
37. Gales AC, Jones RN, Gordon KA, Sader HS, Wilke WW, Beach ML, Pfaller MA, Doern GV; SENTRY Study Group (Latin America). Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY Antimicrobial Surveillance Program (1998). J Antimicrob Chemother 2000;45:295-303. (Pubitemid 30139236)
38. Muratani T. Actual situation in Japan of antimicrobial resistant isolates from patients with urinary tract infection and its control measures. Nippon Rinsho 2007;65(suppl 2, pt 1):513-523.
39. Y Ono 2002 Pseudomonas aeruginosa Nippon Rinsho 60 2150 2155 12440121
40. L Cordero M Sananes B Coley M Hogan M Gelman LW Ayers 2000 Ventilator-associated pneumonia in very low-birth-weight infants at the time of nosocomial bloodstream infection and during airway colonization with Pseudomonas aeruginosa Am J Infect Control 28 333 339 1:STN:280:DC%2BD3M%2Fjt1SlsQ%3D%3D 10.1067/mic.2000.109884 11029131
41. H Kumon N Ono M Iida JC Nickel 1995 Combination effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm Antimicrob Agents Chemother 39 1038 1044 1:CAS:528:DyaK2MXlsVSlsrs%3D 7625785
42. K Shigemura S Arakawa Y Sakai S Kinoshita K Tanaka M Fujisawa 2006 Complicated urinary tract infection caused by Pseudomonas aeruginosa in a single institution (1999-2003) Int J Urol 13 538 542 10.1111/j.1442-2042.2006.01359.x 16771722 (Pubitemid 43760416)